Wordt geladen...
New insights into MicroRNAs involves in drug resistance in diffuse large B cell lymphoma
Diffuse large B cell lymphoma (DLBCL) accounts for nearly 40% of non-Hodgkin’s lymphoma cases. The combined chemotherapy of rituximab, cyclophosphamide, Adriamycin, vincristine, and prednisone (R-CHOP) is considered as the standard therapy for DLBCL; however, nearly half of the patients become refra...
Bewaard in:
| Gepubliceerd in: | Am J Transl Res |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
e-Century Publishing Corporation
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731655/ https://ncbi.nlm.nih.gov/pubmed/26885255 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|